Floatz logo

EVUZAMITIDE

Carpal Tunnel Syndrome (CTS)

University of Tennessee Graduate School of Medicineprotein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Carpal Tunnel Syndrome (CTS) cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Haydarpasa Numune Training and Research Hospital
Phase 4BBB
IBUPROFEN
Universidad Europea de Madrid
Phase 4BB
VITAMIN D
Dr. Ayşe Güç
Phase 4BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Endo USA Inc., a Keenova Therapeutics Company
Phase 4BB
Bont-A
Francesco Bono
Phase 2CCC

View all 11 →

Same molecule, other indications

EVUZAMITIDE is also rated in:

Cardiac AmyloidosisDormant
BB
Indicative ·
69 / 100
View asset →
amyloidosisDormant
BB
Indicative ·
64 / 100
View asset →
Transthyretin AmyloidosisDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →